Under construction – not a live service
Sign in

NCT05058846Terminated

Pilot Study of Pancreatic Cancer Screening

Source: ClinicalTrials.gov · Last updated 26 Oct 2026

Reason given: Slow accrual

Brief summary (registry, in English)

This study investigates how often abnormal findings from routine magnetic resonance imaging occur in people with genetic mutations in BReast CAncer gene. (BRCA), ataxia telangiectasia mutated gene (ATM), or PALB2 screened for pancreatic cancer. This study may lead to a greater understanding of cancer and potentially, improvements in cancer screening and treatment.

Status (registry)
Terminated
Study type
Observational
Enrollment
64 (actual)
First submitted
17 Sept 2021
Start date
20 Jan 2022
Primary completion date
19 Oct 2026
Lead sponsor
University of California, San Francisco
NCT number
NCT05058846

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior or active pancreatic cancer.

Other

  • Pregnant women are excluded from this study because effects of an MRI on developing fetus is unknown.

Who the study is looking for

  • Ability to provide consent and willing, and able to comply with study procedures Ability to read and speak English
  • GROUP I:
  • Documentation of pathogenic or likely pathogenic germline BRCA 1 and 2, ATM or PALB2 germline genetic mutation
  • No strong family history of pancreatic cancer (defined as having >= 1 first-degree or second-degree relative with a history of pancreatic cancer)
  • Age >= 50 years old at time of consent.
    • GROUP II:
  • Documentation of pathogenic or likely pathogenic germline BRCA 1 and 2, ATM, or PALB2 germline genetic mutation
  • Has strong family history of pancreatic cancer (defined as having >= 1 first-degree or second-degree relative with a history of pancreatic cancer)
  • Age >= 18 years old at time of consent (screening generally begins 10 years prior to the earliest pancreatic cancer in the family)

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of California San FranciscoSan FranciscoUnited StatesUnknown status

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.